Both in Surgical Instruments
Avita Medical vs Orchestra BioMed Holdings
Over the past year RCEL returned +122.7% and OBIO returned +147.2%; their daily moves had a correlation of 0.18.
RCEL +122.7% OBIO +147.2%Growth of $1, one year, split-adjusted
| Metric | RCEL | OBIO |
|---|---|---|
| Price | $11.96 | $6.08 |
| Market cap | $369.9M | $365.4M |
| Today | +2.48% | +3.23% |
| 1 month | +15.6% | +17.3% |
| 6 months | +229.5% | +49.4% |
| Year to date | +246.7% | +46.5% |
| 1 year | +130.0% | +151.2% |
| Revenue growth (YoY) | +17.8% | −89.5% |
| Gross margin | 81.9% | 71.6% |
| Net margin | −35.3% | −27362.5% |
| P/E (TTM) | — | — |
| Price / sales | 4.9× | 11.4× |
| Net cash | -$35.5M | $75.1M |
| Dividend yield | — | — |
| Volatility (60d) | 127.6% | 59.1% |
| Short % of float | 9.6% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).